Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Allena Pharmaceuticals, Inc. ALNA jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
  • Brickell Biotech, Inc. BBI gained 119% to $0.2550.
  • HTG Molecular Diagnostics, Inc. HTGM jumped 29.6% to $1.0891. HTG Molecular Diagnostics highlighted a publication in Frontiers Medicine.
  • Akouos, Inc. AKUS surged 29% to $6.35.
  • Iterum Therapeutics plc ITRM gained 29% to $0.2520.
  • 2U, Inc. TWOU gained 25% to $11.62. Indian online education provider Byju’s offered to buy 2U for $15 a share in cash, valuing the edtech company at more than $1 billion, reported Bloomberg, citing a person familiar with the matter.
  • Agenus Inc. AGEN surged 23% to $2.2750. Agenus announced expanded data from the Phase 1b study of botensilimab and balstilimab in patients with microsatellite stable colorectal cancer.
  • Revelation Biosciences, Inc. REVB shares rose 21.4% to $0.5980. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.
  • Trevi Therapeutics, Inc. TRVI shares gained 20.5% to $2.4350 after the company announced positive results from its Phase 2b/3 PRISM trial of Haduvio in treating prurigo nodularis, a chronic disease characterized by severe pruritus and the presence of nodules, lesions, and excoriations.
  • Integrated Media Technology Limited IMTE shares gained 20.5% to $3.4850.
  • Athersys, Inc. ATHX gained 18.4% to $0.3105.
  • Akebia Therapeutics, Inc. AKBA shares jumped 16% to $0.4065.
  • AdTheorent Holding Company, Inc. ADTH gained 14.8% to $2.87.
  • G Medical Innovations Holdings Ltd GMVD shares surged 13.6% to $0.60.
  • Exicure, Inc. XCUR surged 13.3% to $0.1450.
  • Sol-Gel Technologies Ltd. SLGL gained 12.7% to $5.09.
  • Catalyst Biosciences, Inc. CBIO gained 11.5% to $1.6850. Catalyst Biosciences announced plan to distribute cash to stockholders.
  • Bellerophon Therapeutics, Inc. BLPH surged 9.2% to $1.54.
  • LiveOne, Inc. LVO rose 5.8% to $0.8037 after reporting better-than-expected Q4 results.
  • Beyond Air, Inc. XAIR rose 5.2% to $6.09 after the company posted a narrower FY22 loss. The FDA also approved Beyond Air’s LungFit PH to treat term and near-term neonates with hypoxic respiratory failure (often referred to as persistent pulmonary hypertension of the newborn or PPHN).

 

Losers

  • Aspen Aerogels, Inc. ASPN shares dipped 37.8% to $9.15 following news of a $225 million offering by the company. The offering follows news earlier in June of reduced 2022 bottom-line guidance by the Aspen Aerogels.
  • Agile Therapeutics, Inc. AGRX fell 27% to $1.7650. Agile Therapeutics filed for offering of up to 15.7 million shares.
  • Icosavax, Inc. ICVX fell 25.8% to $6.25 after the company announced interim results from its Phase 1/1b clinical trial of IVX-121, respiratory syncytial virus (RSV) F antigen, in young and older adults.
  • Aileron Therapeutics, Inc. ALRN dipped 25% to $0.3065 as the company announced interim data from its Phase 1b chemoprotection trial of patients with advanced p53-mutated non-small cell lung cancer (NSCLC) undergoing treatment with first-line carboplatin plus pemetrexed with or without immune checkpoint inhibitors.
  • Endo International plc ENDP fell 22.5% to $0.5499. Endo International shares jumped 85% on Tuesday in possible reaction to the recent overturning of Roe v Wade. The company's Paladin Labs subsidiary produces Plan B pills.
  • Heliogen, Inc. HLGN dipped 21.4% to $1.9650.
  • Bed Bath & Beyond Inc. BBBY dropped 20.7% to $5.18 after the company reported worse-than-expected Q1 EPS and sales results.
  • ToughBuilt Industries, Inc. TBLT fell 19.8% to $2.2850.
  • Evofem Biosciences, Inc. EVFM dipped 19.6% to $0.8601. Evofem Biosciences recently announced an agreement with a pharmacy benefit manager.
  • Grove Collaborative Holdings, Inc. GROV fell 17.8% to $3.88.
  • Quhuo Limited QH fell 16% to $0.3515.
  • Lytus Technologies Holdings PTV. Ltd. LYT dropped 16% to $5.88.
  • Tenax Therapeutics, Inc. TENX dropped 15.7% to $0.2990.
  • CNFinance Holdings Limited CNF fell 15.3% to $2.72.
  • Carnival plc CUK shares fell 15.2% to $7.97 after Morgan Stanley maintained the stock with an Underweight rating and lowered its price target from $13 to $7.
  • Lindblad Expeditions Holdings, Inc. LIND fell 15.2% to $7.62.
  • IDEX Biometrics ASA IDBA dropped 14.5% to $9.50.
  • Revlon, Inc. REV shares fell 14.1% to $4.75 after dipping 17% on Tuesday. Reliance Industries recently, in a press release, declined comment on rumor of Revlon takeover interest.
  • Pagaya Technologies Ltd. PGY dipped 12.4% to $4.66.
  • Tenax Therapeutics, Inc. TENX fell 11.8% to $0.3130 after dropping around 8% on Tuesday.
  • Wallbox N.V. WBX dipped 11.3% to $9.27.
  • Issuer Direct Corporation ISDR dropped 10.6% to $21.64.
  • Upstart Holdings, Inc. UPST shares fell 10.1% to $32.24 after declining around 8% on Tuesday.
  • InflaRx N.V. IFRX fell 7.2% to $1.4111. InflaRx shares jumped over 40% on Tuesday after the FDA granted the company Orphan Drug Designation for the treatment of pyoderma gangrenosum.
  • Clarus Therapeutics Holdings, Inc. CRXT shares fell 5.8% to $0.4050. Clarus Therapeutics recently filed prospectus relates to the offer and sale by selling securityholder of up to 1.3 million shares of common stock.

Posted In: Mid-Day MoversTop GainersNewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.